Colin Bond is Non-Executive Chairman at European ScreeningPort GmbH and Chief Financial Officer for Vifor Pharma AG, Chief Financial Officer for Vifor Pharma Management AG (a subsidiary of Vifor Pharma AG).

He is also on the board of Siegfried Holding AG and BioPharma Credit PLC and Member of Royal Pharmaceutical Society of Great Britain.

In the past Colin Bond occupied the position of Chief Financial Officer of Evotec SE, Chief Financial Officer of Great Lakes Chemical Corp., Chief Financial Officer of Jet Aviation Management AG, Chief Financial Officer at Novelis AG, Chief Financial Officer of Novelis Europe Holdings Ltd., Chief Financial Officer of Ecolab (Schweiz) GmbH, Auditor for Procter & Gamble AG, Auditor for Arthur Andersen AG and Auditor of PricewaterhouseCoopers LLP.

Colin Bond received an MBA from London Business School and an undergraduate degree from the University of Aston.